XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Tables)
 9 Months Ended
Sep. 30, 2017
Business Combinations [Abstract]  
Schedule Of Joint Venture Payments [Table Text Block]
The joint venture formation was as follows ($000’s):
 
Patent license rights
 
$
1,045
 
Noncontrolling interests
 
 
(667)
 
Cash paid at formation
 
$
378